Your browser doesn't support javascript.
loading
Correction to: Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
Khanna, Sahil; Assi, Maha; Lee, Christine; Yoho, David; Louie, Thomas; Knapple, Whitfield; Aguilar, Humberto; Garcia-Diaz, Julia; Wang, Gary P; Berry, Scott M; Marion, Joe; Su, Xin; Braun, Tricia; Bancke, Lindy; Feuerstadt, Paul.
Afiliación
  • Khanna S; Gastroenterology and Hepatology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA. Khanna.Sahil@mayo.edu.
  • Assi M; University of Kansas School of Medicine-Wichita, Wichita, KS, USA.
  • Lee C; University of Victoria, Victoria, BC, Canada.
  • Yoho D; Kaiser Permanente Springfield Medical Center, Springfield, VA, USA.
  • Louie T; University of Calgary, Calgary, AB, Canada.
  • Knapple W; Arkansas Gastroenterology, North Little Rock, AR, USA.
  • Aguilar H; Louisiana Research Center, Shreveport, LA, USA.
  • Garcia-Diaz J; Ochsner Clinic, New Orleans, LA, USA.
  • Wang GP; University of Florida, Gainesville, FL, USA.
  • Berry SM; Berry Consultants, LLC, Austin, TX, USA.
  • Marion J; Berry Consultants, LLC, Austin, TX, USA.
  • Su X; Formerly of Rebiotix, Inc, Roseville, MN, USA.
  • Braun T; Formerly of Rebiotix, Inc, Roseville, MN, USA.
  • Bancke L; Rebiotix, Inc, Roseville, MN, USA.
  • Feuerstadt P; Yale School of Medicine, New Haven, CT, USA.
Drugs ; 82(15): 1539, 2022 Oct.
Article en En | MEDLINE | ID: mdl-36342618

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Drugs Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Drugs Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos